ASELAGE STEVE bought BCRX
May 24, 2024 · Form 4 insider transaction
ASELAGE STEVE bought 2,500 shares of BioCryst Pharmaceuticals, Inc. at $6.40 per share, a transaction worth $16.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,500
Price
$6.40
Total value
$16.0K
InsiderASELAGE STEVE
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateMay 24, 2024
Filing dateMay 29, 2024
Shares owned after2,500
OwnershipIndirect
10b5-1 planNo
AmendedNo